Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Andrew C Miller"'
Autor:
Thomas J Papadimos, Samara E Soghoian, Prabath Nanayakkara, Sarman Singh, Andrew C Miller, Venkataramanaiah Saddikuti, Achala Upendra Jayatilleke, Siddharth P Dubhashi, Michael S Firstenberg, Vibha Dutta, Vivek Chauhan, Pushpa Sharma, Sagar C Galwankar, Manish Garg, Nicholas Taylor, Stanislaw P Stawicki
Publikováno v:
Journal of Global Infectious Diseases, Vol 12, Iss 4, Pp 167-190 (2020)
As the COVID-19 pandemic continues, important discoveries and considerations emerge regarding the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pathogen; its biological and epidemiological characteristics; and the corresponding psychol
Externí odkaz:
https://doaj.org/article/32cf7967764340f488b9beb75e366e3b
Autor:
Stanislaw P Stawicki, Rebecca Jeanmonod, Andrew C Miller, Lorenzo Paladino, David F Gaieski, Anna Q Yaffee, Annelies De Wulf, Joydeep Grover, Thomas J Papadimos, Christina Bloem, Sagar C Galwankar, Vivek Chauhan, Michael S Firstenberg, Salvatore Di Somma, Donald Jeanmonod, Sona M Garg, Veronica Tucci, Harry L Anderson, Lateef Fatimah, Tamara J Worlton, Siddharth P Dubhashi, Krystal S Glaze, Sagar Sinha, Ijeoma Nnodim Opara, Vikas Yellapu, Dhanashree Kelkar, Ayman El-Menyar, Vimal Krishnan, S Venkataramanaiah, Yan Leyfman, Hassan Ali Saoud Al Thani, Prabath W B Nanayakkara, Sudip Nanda, Eric Cioè-Peña, Indrani Sardesai, Shruti Chandra, Aruna Munasinghe, Vibha Dutta, Silvana Teixeira Dal Ponte, Ricardo Izurieta, Juan A Asensio, Manish Garg
Publikováno v:
Journal of Global Infectious Diseases, Vol 12, Iss 2, Pp 47-93 (2020)
What started as a cluster of patients with a mysterious respiratory illness in Wuhan, China, in December 2019, was later determined to be coronavirus disease 2019 (COVID-19). The pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
Externí odkaz:
https://doaj.org/article/54dde6b83e8d488f9413e54451ed948c
Autor:
Fatemeh Kokabisaghi, Andrew C Miller, Farshid R Bashar, Mahmood Salesi, Ali A K Zarchi, Abdalsamad Keramatfar, Mohammad A Pourhoseingholi, Hosein Amini, Amir Vahedian-Azimi
Publikováno v:
BMJ Global Health, Vol 4, Iss 5 (2019)
International research collaborations improve individual, institutional and governmental capacities to respond to health crises and inequalities but may be greatly affected by political environments. Iran ranks highly in tertiary education, productiv
Externí odkaz:
https://doaj.org/article/c695dc845c5e4e79acffbd1ab4e35548
Autor:
Stanislaw P. Stawicki, Michael S. Firstenberg, Sagar C. Galwankar, Andrew C. Miller, Thomas J. Papadimos
Since the publication of the first volume of Contemporary Developments and Perspectives in International Health Security, a lot has happened in this rapidly evolving area. Perhaps the most dominant global event of the past eighteen months is the COVI
Autor:
Andrew C. Miller, Colton Faza, Alberto A. Castro Bigalli, Abbas M. Khan, Kerry A. Sewell, Alexandra King, Amir Vehedian-Azimi, Shahriar Zehtabchi
Publikováno v:
Archives of Academic Emergency Medicine, Vol 8, Iss 1 (2020)
Introduction:Â Renal colic affects 12% of the U.S. population, accounting for nearly 1% of emergency department (ED) visits. Current recommendations advocate narcotic-limiting multimodal analgesia regimens. The objective of this review is to determi
Externí odkaz:
https://doaj.org/article/ac83a56858af4c6195a5c529ae86196d
Autor:
Christoph U. Correll, Angel S. Angelov, Andrew C. Miller, Peter J. Weiden, Stephen K. Brannan
Publikováno v:
Schizophrenia. 8
KarXT combines xanomeline, an M1/M4 preferring muscarinic agonist with no direct D2 receptor antagonism, with the peripherally restricted anticholinergic trospium. In EMERGENT-1 (NCT03697252), a 5-week, randomized, double-blind, placebo-controlled, p
Publikováno v:
The American journal of psychiatry. 179(9)
Schizophrenia remains a challenging disease to treat effectively with current antipsychotic medications due to their limited efficacy across the entire spectrum of core symptoms as well as their often burdensome side-effect profiles and poor tolerabi
Autor:
Colin Sauder, Luke A. Allen, Elizabeth Baker, Andrew C. Miller, Steven M. Paul, Stephen K. Brannan
Publikováno v:
Translational psychiatry. 12(1)
The muscarinic receptor agonist xanomeline improved cognition in phase 2 trials in Alzheimer’s disease and schizophrenia. We present data on the effect of KarXT (xanomeline–trospium) on cognition in schizophrenia from the 5-week, randomised, doub
Autor:
Peter J, Weiden, Alan, Breier, Sarah, Kavanagh, Andrew C, Miller, Stephen K, Brannan, Steven M, Paul
Publikováno v:
The Journal of Clinical Psychiatry. 83
Autor:
Christoph U. Correll, Andrew C. Miller, Sharon Sawchak, Inder Kaul, Steven M. Paul, Stephen K. Brannan
Publikováno v:
CNS Spectrums. 28:220-220
IntroductionKarXT combines the M1/M4 preferring muscarinic receptor agonist xanomeline and the peripherally restricted anticholinergic trospium. In the phase 2 EMERGENT-1 study, KarXT met the primary endpoint of a significant reduction in Positive an